CompletedPhase 1NCT00528931
A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture
Studying NON RARE IN EUROPE: Familial Dupuytren contracture
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Endo Pharmaceuticals
- Principal Investigator
- Veronica Urdaneta, MDEndo Pharmaceuticals
- Intervention
- collagenase clostridium histolyticum(biological)
- Enrollment
- 16 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2008
Study locations (1)
- Providence Clinical Research, Burbank, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00528931 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Familial Dupuytren contracture
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06956027Ultrasound Features of Dupuytren's DiseaseUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGNANCT07470684Skin Involvement in Dupuytren Surgical Treatment OutcomeUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGNANCT05067764Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's DiseaseElsan
See all trials for NON RARE IN EUROPE: Familial Dupuytren contracture →